Nortech Systems Incorporated
$14.29
▲
1.29%
2026-04-21 08:29:00
www.nortechsys.com
NCM: NSYS
Explore Nortech Systems Incorporated stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$40.36 M
Current Price
$14.29
52W High / Low
$14.61 / $6.5
Stock P/E
—
Book Value
$12.31
Dividend Yield
—
ROCE
2.95%
ROE
-0.73%
Face Value
—
EPS
$-0.09
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
685
Beta
-0.1
Debt / Equity
45.47
Current Ratio
1.88
Quick Ratio
1.19
Forward P/E
—
Price / Sales
0.32
Enterprise Value
$52.7 M
EV / EBITDA
20.84
EV / Revenue
0.45
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Neuronetics, Inc. | $1.58 | — | $109.46 M | — | -28.31% | -1.35% | $4.85 / $0.8 | $0.32 |
| 2. | Smith & Nephew plc | $32.71 | 22.84 | $14.01 B | 2.29% | 9.67% | 11.84% | $1,441.5 / $960.8 | $6.22 |
| 3. | Lifeward Ltd. | $7.52 | — | $11.49 M | — | -155.52% | -1.46% | $18.6 / $4.14 | $5.52 |
| 4. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 5. | Xtant Medical Holdings, Inc. | $0.5 | 15.1 | $75.1 M | — | 11.26% | 10.59% | $0.95 / $0.39 | $0.36 |
| 6. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
| 7. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 30.31 M | 30.48 M | 30.68 M | 26.89 M | 28.62 M | — |
| Operating Profit | 0.9 M | 0.94 M | 0.74 M | -1.35 M | -0.92 M | — |
| Net Profit | 0.9 M | -0.15 M | 0.31 M | -1.32 M | -1.48 M | — |
| EPS in Rs | 0.32 | -0.05 | 0.11 | -0.47 | -0.53 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 118.36 M | 128.13 M | 139.33 M | 134.12 M |
| Operating Profit | 1.24 M | 0.38 M | 5.95 M | 3.87 M |
| Net Profit | -0.25 M | -1.29 M | 6.87 M | 2.01 M |
| EPS in Rs | -0.09 | -0.46 | 2.47 | 0.72 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 71.92 M | 72.44 M | 75.13 M | 69.54 M |
| Total Liabilities | 37.37 M | 38.43 M | 39.78 M | 41.46 M |
| Equity | 34.55 M | 34.01 M | 35.34 M | 28.08 M |
| Current Assets | 56.15 M | 55.31 M | 58.79 M | 54.86 M |
| Current Liabilities | 29.84 M | 21.43 M | 26.58 M | 26.4 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.74 M | -2.25 M | 1.77 M | 5.4 M |
| Investing CF | -0.16 M | -1.26 M | -1.28 M | -2.43 M |
| Financing CF | -1.87 M | 2.77 M | -1.28 M | -2.67 M |
| Free CF | 2.08 M | -3.52 M | 0.48 M | 2.96 M |
| Capex | -0.66 M | -1.27 M | -1.28 M | -2.44 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -8.04% | 3.88% | — | — |
| Earnings Growth % | -118.84% | 241.99% | — | — |
| Profit Margin % | -1.01% | 4.93% | 1.5% | — |
| Operating Margin % | 0.29% | 4.27% | 2.89% | — |
| Gross Margin % | 13.05% | 16.58% | 15.27% | — |
| EBITDA Margin % | 1.2% | 5.74% | 4.33% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.